Loading clinical trials...
Loading clinical trials...
According to the World Health Organization, breast cancer is the most common cancer in women, and is responsible for 686,000 new cases every year. The WHO also posit that nearly 420,000 women perished...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Abramson Cancer Center at Penn Medicine
NCT06075953 · Ductal Carcinoma in Situ
NCT07206121 · Breast Cancer, Breast-conserving Surgery, and more
NCT06666439 · Metastatic Invasive Lobular Carcinoma (mILC)
NCT07331506 · Breast Cancer Detection, Breast Cancer Early Stage Breast Cancer (Stage 1-3), and more
NCT05053152 · Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, and more
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions